Liraglutide Drugs - BNF

liraglutide  Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist  liraglutide mg and mg, respectively This result was statistical significantly greater than with any comparator therapy

Simultaneously, liraglutide lowers inappropriately high glucagon secretion, also in a glucose-dependent manner Thus, when blood glucose is high, insulin Conclusions Liraglutide helps to induce and sustain weight loss in patients with obesity Its efficacy is comparable to other available agents

We have previously demonstrated that a 12-week addition of liraglutide to insulin therapy in patients with type 1 diabetes results in In conclusion, the GLP-1R agonist liraglutide rapidly improves insulin sensitivity and fasting and postprandial blood glucose levels as early as